Manidipine treatment in patients with albuminuria not sufficiently reduced with renin–angiotensin system blockers

References

• Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens.25(6), 1105–1187 (2007).
   PubMed Web of Science ®Google Scholar
• Hillege HL, Fidler V, Diercks GFH et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population, microalbuminuria, and risk of ischemic heart disease. Hypertension106(14), 1777–1782 (2002).
   Google Scholar
• De Leeuw PW, Ruilope LM, Palmer CR et al. Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial. Arch. Intern. Med.164(22), 2459–2464 (2004).
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Mann JF, Yi Q et al.; HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA286(4), 421–426 (2001).
   PubMed Web of Science ®Google Scholar
• Clausen P, Jensen JS, Jensen G et al. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation103(14), 1869–1874 (2001).
   PubMed Web of Science ®Google Scholar
• Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with Type 2 diabetes and nephropathy. N. Engl. J. Med.345(12), 861–869 (2001).
   PubMed Web of Science ®Google Scholar
• Schrader J, Luders S, Kulschewski A et al. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study). J. Hypertens.24(3), 541–548 (2006).
   PubMed Web of Science ®Google Scholar
• Ninomiya T, Perkovic V, de Galan BE et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J. Am. Soc. Nephrol.20(8), 1813–1821 (2009)
   PubMed Web of Science ®Google Scholar
• Tonelli M, Jose P, Curhan G et al. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. Br. Med. J.332(7555), 1426–1431 (2006).
   PubMedGoogle Scholar
• Parving HH. Hypertension and diabetes: the scope of the problem. Blood Press. Suppl.2, 25–31 (2001).
   PubMedGoogle Scholar
• Martínez Martín FJ. Calcium channel-blockers for managing metabolic syndrome-associated hypertension. Trials with manidipine. Nefrologia27(Suppl. 6), 26–35 (2007).
   PubMed Web of Science ®Google Scholar
• Richard S. Vascular effects of calcium channel antagonists: new evidence. Drugs65(Suppl. 2), 1–10 (2005).
   PubMed Web of Science ®Google Scholar
• Hirakata H, Iino K, Ishida I et al. Effects of a new calcium antagonist, manidipine, on the renal hemodynamics and the vasoactive humoral factors in patients with diabetes mellitus. Blood Press. Suppl.3, 124–129 (1992).
   PubMedGoogle Scholar
• Ruilope LM, Zanchetti A, Julius S et al. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. J. Hypertens.25(7), 1473–1479 (2007).
   PubMed Web of Science ®Google Scholar
• Klahr S, Levey AS, Beck GJ et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N. Engl. J. Med.330(13), 877–884 (1994).
   PubMed Web of Science ®Google Scholar
• Peterson JC, Adler S, Burkart JM et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann. Intern. Med.123(10), 754–762 (1995).
   PubMed Web of Science ®Google Scholar
• Barrios V, Banegas JR, Ruilope LM, Rodicio JL. Evolution of blood pressure control in Spain. J. Hypertens.25(9), 1975–1977 (2007).
   PubMed Web of Science ®Google Scholar
• Sarafidis PA, Li S, Chen SC et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am. J. Med.121(4), 332–340 (2008).
   PubMed Web of Science ®Google Scholar
• Fagerudd J, Forsblom C, Pettersson-Fernholm K, Groop PH; FinnDiane Study Group. Implementation of guidelines for the prevention of diabetic nephropathy. Diabetes Care27(3), 803–804 (2004).
   PubMed Web of Science ®Google Scholar
• Martinez-Martin FJ, Saiz-Satjes M. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study. Expert Rev. Cardiovasc. Ther.6(10), 1347–1355 (2008).
   PubMedGoogle Scholar
• Martínez Martín FJ. Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study. Expert Rev. Cardiovasc. Ther.7(7), 863–869 (2009).
   PubMedGoogle Scholar
• Fogari R, Zoppi A, Mugellini A, Preti P, Corradi L, Lusardi P. Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives. Cardiovasc. Drugs Ther.13(3), 243–248 (1999).
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Omboni S, La Commare P, De Cesaris R, Palatini P. Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension. J. Cardiovasc. Pharmacol.38(4), 642–650 (2001).
   PubMed Web of Science ®Google Scholar
• Fogari R, Zoppi A, Lusardi P, Preti P, Poletti L, Mugellini A. Evaluation by 24-hour ambulatory blood pressure monitoring of efficacy of manidipine hydrochloride 10, 20 or 40 mg once daily as compared to placebo in treating mild to moderate essential hypertension: a double-blind, randomized, parallel group, placebo-controlled study. Blood Press. Suppl.5, 16–23 (1996).
   PubMedGoogle Scholar
• Kohlmann O Jr, Roca-Cusachs A, Laurent S, Schmieder RE, Wenzel RR, Fogari R. Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with Type 2 diabetes and microalbuminuria. Adv. Ther.26(3), 313–324 (2009).
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Rastenyte D, Birkenhäger WH et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N. Engl. J. Med.340(9), 677–684 (1999).
   PubMed Web of Science ®Google Scholar
• Agodoa LY, Appel L, Bakris GL et al.; African American Study of Kidney Disease and Hypertension (AASK) Study Group. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA285(21), 2719–2728 (2001).
   PubMed Web of Science ®Google Scholar
• Hayashi K, Wakino S, Sugano N et al. Ca2+ channel subtypes and pharmacology in the kidney. Circ. Res.100(3), 342–353 (2007).
   PubMed Web of Science ®Google Scholar
• Fogari R, Mugellini A, Zoppi A et al. Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. Eur. J. Clin. Pharmacol.61(7), 483–490 (2005).
   PubMed Web of Science ®Google Scholar
• Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med.351(13), 1296–1305 (2004).
   PubMed Web of Science ®Google Scholar
• Hallan SI, Dahl K, Oien CM et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. Br. Med. J.333(7577), 1047–1054 (2006).
   PubMed Web of Science ®Google Scholar
• Mann JF, Schmieder RE, McQueen M et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet372(9638), 547–553 (2008).
   PubMed Web of Science ®Google Scholar
• Smith DH. Fixed-dose combination antihypertensives and reduction in target organ damage: are they all the same? Am. J. Cardiovasc. Drugs7(6), 413–422 (2007).
   PubMed Web of Science ®Google Scholar